Biden’s ‘Test to Treat’ Program Rolled Out This Week, Questions Still Remain

President Biden’s ‘test to treat’ program started rolling out this week to praise and also many questions. People will be able will be able to walk into participating pharmacies or clinics and if they test positive for Covid, they will be given a free course of Pfizer or Merck’s antiviral pills. Questions are still floating around about supply of pills, rapid tests, and concerns over drug to drug interactions. Katie Shepherd, health and science reporter at The Washington Post, joins us for more. Learn more about your ad-choices at https://www.iheartpodcastnetwork.com